Table 1: Demographic and baseline data of enrolled subjects

		N		Percentage (%)
A
Gender
Male		35		34
Female		68		66
Total		103
Race
Caucasian		73		71
African American		18		17
Hispanic		5		5
Asian		3		3
Other		4		4
Total		103
B
Significant ophthalmic history
Primary open angle glaucoma		93		90
Ocular hypertension		18		17.5
Cataracts		13		12.6
Pseudophakia		3		2.9
Central retinal vein occlusion		1		1.0
Diabetic retinopathy		1		1.0
Macular degeneration		4		3.9
Significant dry eyes		1		1.0
Pan retinal photocoagulation		2		1.9
Selective laser trabeculoplasty		1		1.0
Ophthalmic medication history
Betimol (timolol hemihydrate)		67		65.0
Istalol (timolol maleate in sorbate)		39		37.9
Travatan Z (travoprost BAC free)		17		16.5
Xalatan (latanoprost)		12		11.7
Lumigan (bimatoprost)		10		9.7
Diamox (acetazolamide)		1		1.0
Azopt (brinzolamide)		1		1.0
Therapy type
Monotherapy		63		61.2
Adjunctive therapy		40		38.8